Genome-wide genetic associations with IFNγ response to smallpox vaccine.
Smallpox is a deadly and debilitating disease that killed hundreds of millions of people in the past century alone. The use of Vaccinia virus-based smallpox vaccines led to the eradication of smallpox. These vaccines are remarkably effective, inducing the characteristic pustule or "take" at the vaccine site in >97 % of recipients, and inducing a wide spectrum of long-lasting humoral and cellular immune responses. The mechanisms behind inter-individual vaccine-response variability are likely to involve host genetic variation, but have not been fully characterized. We report here the first smallpox vaccine response genome-wide association study of over 1,000 recent recipients of Dryvax(®). The data presented here focus on cellular immune responses as measured by both production of secreted IFNγ and quantitation of IFNγ secreting cells by ELISPOT assay. We identified multiple significant SNP associations in genes (RASA1, ADRA1D, TCF7L1, FAS) that are critical components of signaling pathways that directly control lymphocyte IFNγ production or cytotoxic T cell function. Similarly, we found many associations with SNPs located in genes integral to nerve cell function; findings that, given the complex interplay between the nervous and immune systems, deserve closer examination in follow-up studies.
Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, MN 55905, USA.
Richard B
RB
Kennedy
Inna G
IG
Ovsyannikova
V Shane
VS
Pankratz
Iana H
IH
Haralambieva
Robert A
RA
Vierkant
Robert M
RM
Jacobson
Gregory A
GA
Poland
D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D055106:Genome-Wide Association Study; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis*; D020641:Polymorphism, Single Nucleotide; D025341:Principal Component Analysis; D011786:Quality Control; D012900:Smallpox Vaccine / Q000276:immunology*
D012900:Smallpox Vaccine; D007371:Interferon-gamma